Polymorphs

US10301313B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Peter Sieger · Mittelbiberach, DE
• Dirk Kemmer · Windesheim, DE
• Peter KOHLBAUER · Biberach an der Riß, DE
• Thomas Nicola · Ingelheim am Rhein, DE
• Martin Renz · Bebenhaus, DE

Key dates

• Filing date: Oct 5, 2017
• Grant date: May 28, 2019
• Expiry date: Oct 5, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07B2200/13
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to polymorphous crystal modifications of a DPP-IV inhibitor, the preparation thereof and the use thereof for preparing a medicament.